High Blood Pressure (Hypertension) Completed Phase 3 Trials for Olmesartan (DB00275)

Also known as: HTN / Hypertension(HTN) / Hypertensive / Hypertension / High Blood Pressure / Blood High Pressure / Blood Pressure, High / High Blood Pressures / Blood pressure high / Essential (primary) hypertension / HT / HBP / Hypertension NOS / Hypertension arterial

IndicationStatusPhase
DBCOND0040789 (High Blood Pressure (Hypertension))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00649389Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionTreatment
NCT00185133Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionTreatment
NCT00676845Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial ProtectionTreatment
NCT00891267Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic SyndromeTreatment
NCT02609490Azilsartan in Chinese Patients With Mild and Moderate HypertensionTreatment
NCT00523744Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled HypertensionTreatment
NCT00696436An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.Treatment
NCT00696241Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionTreatment
NCT01613209Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ AmlodipineTreatment
NCT01764295Clinical Study for Patients With Hypertension Associated With DyslipidemiaTreatment
NCT01876368Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to OlmesartanTreatment